MYD88 L265P Recombinant Rabbit Monoclonal Antibody

Myeloid differentiation factor 88 (MYD88), a primary differentiation response gene in Myeloid precursors, was discovered in 1990s. MYD88 is a universal connexin containing three main structures: N-terminal death domain (DD), intermediate connexin domain (ID), and C-terminal Toll/ interleukin-1 receptor domain (TIR). After ligand binding, the cytoplasmic TIR domain of toll-like receptor (TLR) or IL1R binds to TIR of MYD88.

Specifications

Catalog No.
BX50265
Clone No.
BP6242
Application
IHC-P
Subcellular location
Cytoplasm
Control
293T cell MYD88 L265P
Recommended method
HIER
Volume
100μl/vial, 1ml/vial
Dilution
1:100-1:200
Immunogen
Synthetic peptide. This information is proprietary to Biolynx.

Reference

1. Vu N. Ngo, et al. Nature. 2011 February 3; 470(7332): 115–119.
2. Xose S. Puente, et al. Nature. 2011 JULY 7; 475: 110–115.

Support Documents

Order

  • E-mail : sales@biolynx.cn

Contact Us

Address
Hangzhou Bailing (Biolynx)  Biotechnology Co., Ltd. Room 1303 Bldg 5, #688 Bin’an Road Tianhe High-tech Park, Binjiang District Hangzhou, Zhejiang, China
310052
Phone & Fax
+86 571 88177680
+86 571 88177681
Web & Mail
Email:sales@biolynx.cn
www.biolynxtec.com

Follow Us

Scan QR Codes on Your Phone